+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Interventional Pulmonology Market Size, Share & Industry Trends Analysis Report By Product, By Indication (Asthma, Lung Cancer, COPD, Tracheal & Bronchial Stenosis and Others), By End-user, By Regional Outlook and Forecast, 2023-2029

  • PDF Icon

    Report

  • 270 Pages
  • April 2023
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5806211
Description Jump to:
The Global Interventional Pulmonology Market size is expected to reach $5.9 billion by 2029, rising at a market growth of 6.9% CAGR during the forecast period.

Interventional pulmonology is a medical specialty focusing on the minimally invasive diagnosis and treatment of lung problems. Interventional pulmonology is utilized for procedures such as bronchoscopy and thoracoscopy. These treatments are often performed via small incisions, which decreases the risk of problems and accelerates healing. Governments in several nations worldwide are taking steps to enhance healthcare facilities and provide effective treatments for respiratory disorders.



As a result, pulmonologists continually search for novel and inventive diagnostic and therapeutic approaches for respiratory disorders. In addition, increased public awareness of respiratory disorders has increased early diagnosis and treatment, improving patient outcomes.

Governments and insurance companies across the globe are rapidly enacting rules that encourage the use of generic medications, hence intensifying market competition. This is because generic medications are viewed as cost-effective options that can drastically lower healthcare expenses for governments and insurance companies.

The rising demand for pulmonology therapies has increased R&D spending on novel medications and devices. This is helping to enhance the detection and treatment of respiratory disorders, giving a substantial opportunity for expansion in interventional pulmonology. In addition, the incidence of respiratory disorders like COPD and lung cancer is increasing as the population ages. This boosts the need for pulmonology therapies, creating significant growth potential for key players operating in the interventional pulmonology market.

COVID-19 Impact Analysis

Due to supply chain disruptions brought on by the pandemic, prices have increased, and shortages have occurred for several pulmonology-related products. In addition, many healthcare facilities postponed or discontinued non-emergency procedures, including sleep studies and pulmonary function tests, which reduced revenue for pulmonologists and associated enterprises. Also, more research and development have created new interventional pulmonology therapies to treat COVID-19 patients, increasing market competitiveness. However, the majority of government financing was directed toward the healthcare sector due to the rapid expansion of COVID-19 pandemic. The interventional pulmonology market has significantly been impacted by the COVID-19 pandemic.

Market Growth Factors

Growing spending on healthcare for better infrastructure

The acceptance and usage of modern medical technologies in healthcare institutions, such as hospitals, would be bolstered by enhanced healthcare infrastructure and greater healthcare spending by the appropriate public authorities. This would increase the demand for interventional pulmonology. India, Brazil, and Mexico are growing economies with a significant COPD patient population. COPD patients require breathing help regularly. The market's long-term survival will be bolstered by an increase in patient disposable income & economic growth in these emerging markets.

Grown occurrence of lung cancer

The multiple benefits of electromagnetic navigation bronchoscopy, specifically its precision, greater accuracy, and ability to generate a 3D (three-dimensional) bronchial map, are likely to be recognized in the coming years as critical growth factors for the demand for electromagnetic navigation bronchoscopy. In addition to this, it is anticipated that the increasing incidence of bronchial diseases such as lung cancer will be one of the primary drivers for the need for electromagnetic navigation bronchoscopy systems throughout the course of the projected period.

Market Restraining Factors

Availability of alternatives options & strict regulations

The dangers of bronchoscopy procedures, like contamination and infection following a bronchoscopy, are lowering adoption rates. The dangers associated with bronchoscopies, such as bleeding, respiratory problems, and low blood oxygen levels during the procedure, are another factor restricting the market. The likelihood that a patient would experience a post-bronchoscopy infection has increased with the emergence of methicillin-resistant staphylococcus aureus and other resistant bacteria. The strict regulations, and the availability of alternative options is predicted to support the market’s expansion.

End-user Outlook

Based on end-user, the interventional pulmonology market is segmented into hospitals, ambulatory surgical centers, diagnostic centers, specialty clinics, and others. The ambulatory surgical centers segment garnered a significant revenue share in the interventional pulmonology market in 2022. Ambulatory surgical centers are less expensive than regular hospitals, providing a shorter stay following surgery. Also, the availability of more minimally invasive procedures and the growth of ambulatory surgery centers influence the market.



Product Outlook

On the basis of product, the interventional pulmonology market is fragmented into bronchoscopes, electromagnetic navigation bronchoscopy system, pleuroscopes, respiratory endotherapy devices, airway stents, pleural catheters, endobronchial valves, and bronchial thermoplasty systems. In 2022, the respiratory endotherapy devices segment procured a promising growth rate in the interventional pulmonology market. The global need for endoscopy equipment has increased along with the prevalence of respiratory disease and the aging population, increasing the demand for respiratory endotherapy devices.

Indication Outlook

By indication, the interventional pulmonology market is bifurcated into asthma, COPD, lung cancer, tracheal & bronchial stenosis and others. In 2022, the asthma segment dominated the interventional pulmonology market with the maximum revenue share. All ages are affected by asthma, but children are the ones it impacts the most. It is a condition marked by recurrent episodes of wheezing and shortness of breath that differ in intensity and frequency from individual to individual. Due to reasons such as an aging population and rising asthma prevalence, the market in the asthma segment is growing.

Regional Outlook

Region wise, the interventional pulmonology market is analyzed across North America, Europe, Asia Pacific and LAMEA. In 2022, the North America region led the interventional pulmonology market by generating the highest revenue share. The market is expanding due to rising healthcare expenditures, technological advancements in the diagnosis and treatment of pulmonary disorders, and a shift toward less-invasive procedures in industrialized nations such as the United States. In addition, the occurrence of lung diseases caused by heavy smoking and the rise in air pollution are significant market growth drivers.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Boston Scientific Corporation, Becton, Dickinson and Company, Olympus Corporation, Fujifilm Holdings Corporation, ICU Medical, Inc. (Smiths Medical), HUGER Medical Instrument Co., Ltd, Cook Medical, Inc. (Cook Group), Clarus Medical LLC and Vygon SAS.

Scope of the Study

By Product

  • Bronchoscopes
  • Electromagnetic Navigation Bronchoscopy System
  • Bronchial Thermoplasty Systems
  • Pleuroscopes
  • Respiratory Endotherapy Devices
  • Endobronchial Valves
  • Airway Stents & Pleural Catheters

By Indication

  • Asthma
  • Lung Cancer
  • COPD
  • Tracheal & Bronchial Stenosis
  • Others

By End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Specialty Clinics
  • Others

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Medtronic PLC
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Olympus Corporation
  • Fujifilm Holdings Corporation
  • ICU Medical, Inc. (Smiths Medical)
  • HUGER Medical Instrument Co., Ltd
  • Cook Medical, Inc. (Cook Group)
  • Clarus Medical LLC
  • Vygon SAS

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Interventional Pulmonology Market, by Product
1.4.2 Global Interventional Pulmonology Market, by Indication
1.4.3 Global Interventional Pulmonology Market, by End-user
1.4.4 Global Interventional Pulmonology Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Interventional Pulmonology Market by Product
3.1 Global Bronchoscopes Market by Region
3.2 Global Electromagnetic Navigation Bronchoscopy System Market by Region
3.3 Global Bronchial Thermoplasty Systems Market by Region
3.4 Global Pleuroscopes Market by Region
3.5 Global Respiratory Endotherapy Devices Market by Region
3.6 Global Endobronchial Valves Market by Region
3.7 Global Airway Stents & Pleural Catheters Market by Region
Chapter 4. Global Interventional Pulmonology Market by Indication
4.1 Global Asthma Market by Region
4.2 Global Lung Cancer Market by Region
4.3 Global COPD Market by Region
4.4 Global Tracheal & Bronchial Stenosis Market by Region
4.5 Global Others Market by Region
Chapter 5. Global Interventional Pulmonology Market by End-user
5.1 Global Hospitals Market by Region
5.2 Global Ambulatory Surgical Centers Market by Region
5.3 Global Diagnostic Centers Market by Region
5.4 Global Specialty Clinics Market by Region
5.5 Global Others Market by Region
Chapter 6. Global Interventional Pulmonology Market by Region
6.1 North America Interventional Pulmonology Market
6.1.1 North America Interventional Pulmonology Market by Product
6.1.1.1 North America Bronchoscopes Market by Country
6.1.1.2 North America Electromagnetic Navigation Bronchoscopy System Market by Country
6.1.1.3 North America Bronchial Thermoplasty Systems Market by Country
6.1.1.4 North America Pleuroscopes Market by Country
6.1.1.5 North America Respiratory Endotherapy Devices Market by Country
6.1.1.6 North America Endobronchial Valves Market by Country
6.1.1.7 North America Airway Stents & Pleural Catheters Market by Country
6.1.2 North America Interventional Pulmonology Market by Indication
6.1.2.1 North America Asthma Market by Country
6.1.2.2 North America Lung Cancer Market by Country
6.1.2.3 North America COPD Market by Country
6.1.2.4 North America Tracheal & Bronchial Stenosis Market by Country
6.1.2.5 North America Others Market by Country
6.1.3 North America Interventional Pulmonology Market by End-user
6.1.3.1 North America Hospitals Market by Country
6.1.3.2 North America Ambulatory Surgical Centers Market by Country
6.1.3.3 North America Diagnostic Centers Market by Country
6.1.3.4 North America Specialty Clinics Market by Country
6.1.3.5 North America Others Market by Country
6.1.4 North America Interventional Pulmonology Market by Country
6.1.4.1 US Interventional Pulmonology Market
6.1.4.1.1 US Interventional Pulmonology Market by Product
6.1.4.1.2 US Interventional Pulmonology Market by Indication
6.1.4.1.3 US Interventional Pulmonology Market by End-user
6.1.4.2 Canada Interventional Pulmonology Market
6.1.4.2.1 Canada Interventional Pulmonology Market by Product
6.1.4.2.2 Canada Interventional Pulmonology Market by Indication
6.1.4.2.3 Canada Interventional Pulmonology Market by End-user
6.1.4.3 Mexico Interventional Pulmonology Market
6.1.4.3.1 Mexico Interventional Pulmonology Market by Product
6.1.4.3.2 Mexico Interventional Pulmonology Market by Indication
6.1.4.3.3 Mexico Interventional Pulmonology Market by End-user
6.1.4.4 Rest of North America Interventional Pulmonology Market
6.1.4.4.1 Rest of North America Interventional Pulmonology Market by Product
6.1.4.4.2 Rest of North America Interventional Pulmonology Market by Indication
6.1.4.4.3 Rest of North America Interventional Pulmonology Market by End-user
6.2 Europe Interventional Pulmonology Market
6.2.1 Europe Interventional Pulmonology Market by Product
6.2.1.1 Europe Bronchoscopes Market by Country
6.2.1.2 Europe Electromagnetic Navigation Bronchoscopy System Market by Country
6.2.1.3 Europe Bronchial Thermoplasty Systems Market by Country
6.2.1.4 Europe Pleuroscopes Market by Country
6.2.1.5 Europe Respiratory Endotherapy Devices Market by Country
6.2.1.6 Europe Endobronchial Valves Market by Country
6.2.1.7 Europe Airway Stents & Pleural Catheters Market by Country
6.2.2 Europe Interventional Pulmonology Market by Indication
6.2.2.1 Europe Asthma Market by Country
6.2.2.2 Europe Lung Cancer Market by Country
6.2.2.3 Europe COPD Market by Country
6.2.2.4 Europe Tracheal & Bronchial Stenosis Market by Country
6.2.2.5 Europe Others Market by Country
6.2.3 Europe Interventional Pulmonology Market by End-user
6.2.3.1 Europe Hospitals Market by Country
6.2.3.2 Europe Ambulatory Surgical Centers Market by Country
6.2.3.3 Europe Diagnostic Centers Market by Country
6.2.3.4 Europe Specialty Clinics Market by Country
6.2.3.5 Europe Others Market by Country
6.2.4 Europe Interventional Pulmonology Market by Country
6.2.4.1 Germany Interventional Pulmonology Market
6.2.4.1.1 Germany Interventional Pulmonology Market by Product
6.2.4.1.2 Germany Interventional Pulmonology Market by Indication
6.2.4.1.3 Germany Interventional Pulmonology Market by End-user
6.2.4.2 UK Interventional Pulmonology Market
6.2.4.2.1 UK Interventional Pulmonology Market by Product
6.2.4.2.2 UK Interventional Pulmonology Market by Indication
6.2.4.2.3 UK Interventional Pulmonology Market by End-user
6.2.4.3 France Interventional Pulmonology Market
6.2.4.3.1 France Interventional Pulmonology Market by Product
6.2.4.3.2 France Interventional Pulmonology Market by Indication
6.2.4.3.3 France Interventional Pulmonology Market by End-user
6.2.4.4 Russia Interventional Pulmonology Market
6.2.4.4.1 Russia Interventional Pulmonology Market by Product
6.2.4.4.2 Russia Interventional Pulmonology Market by Indication
6.2.4.4.3 Russia Interventional Pulmonology Market by End-user
6.2.4.5 Spain Interventional Pulmonology Market
6.2.4.5.1 Spain Interventional Pulmonology Market by Product
6.2.4.5.2 Spain Interventional Pulmonology Market by Indication
6.2.4.5.3 Spain Interventional Pulmonology Market by End-user
6.2.4.6 Italy Interventional Pulmonology Market
6.2.4.6.1 Italy Interventional Pulmonology Market by Product
6.2.4.6.2 Italy Interventional Pulmonology Market by Indication
6.2.4.6.3 Italy Interventional Pulmonology Market by End-user
6.2.4.7 Rest of Europe Interventional Pulmonology Market
6.2.4.7.1 Rest of Europe Interventional Pulmonology Market by Product
6.2.4.7.2 Rest of Europe Interventional Pulmonology Market by Indication
6.2.4.7.3 Rest of Europe Interventional Pulmonology Market by End-user
6.3 Asia Pacific Interventional Pulmonology Market
6.3.1 Asia Pacific Interventional Pulmonology Market by Product
6.3.1.1 Asia Pacific Bronchoscopes Market by Country
6.3.1.2 Asia Pacific Electromagnetic Navigation Bronchoscopy System Market by Country
6.3.1.3 Asia Pacific Bronchial Thermoplasty Systems Market by Country
6.3.1.4 Asia Pacific Pleuroscopes Market by Country
6.3.1.5 Asia Pacific Respiratory Endotherapy Devices Market by Country
6.3.1.6 Asia Pacific Endobronchial Valves Market by Country
6.3.1.7 Asia Pacific Airway Stents & Pleural Catheters Market by Country
6.3.2 Asia Pacific Interventional Pulmonology Market by Indication
6.3.2.1 Asia Pacific Asthma Market by Country
6.3.2.2 Asia Pacific Lung Cancer Market by Country
6.3.2.3 Asia Pacific COPD Market by Country
6.3.2.4 Asia Pacific Tracheal & Bronchial Stenosis Market by Country
6.3.2.5 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Interventional Pulmonology Market by End-user
6.3.3.1 Asia Pacific Hospitals Market by Country
6.3.3.2 Asia Pacific Ambulatory Surgical Centers Market by Country
6.3.3.3 Asia Pacific Diagnostic Centers Market by Country
6.3.3.4 Asia Pacific Specialty Clinics Market by Country
6.3.3.5 Asia Pacific Others Market by Country
6.3.4 Asia Pacific Interventional Pulmonology Market by Country
6.3.4.1 China Interventional Pulmonology Market
6.3.4.1.1 China Interventional Pulmonology Market by Product
6.3.4.1.2 China Interventional Pulmonology Market by Indication
6.3.4.1.3 China Interventional Pulmonology Market by End-user
6.3.4.2 Japan Interventional Pulmonology Market
6.3.4.2.1 Japan Interventional Pulmonology Market by Product
6.3.4.2.2 Japan Interventional Pulmonology Market by Indication
6.3.4.2.3 Japan Interventional Pulmonology Market by End-user
6.3.4.3 India Interventional Pulmonology Market
6.3.4.3.1 India Interventional Pulmonology Market by Product
6.3.4.3.2 India Interventional Pulmonology Market by Indication
6.3.4.3.3 India Interventional Pulmonology Market by End-user
6.3.4.4 South Korea Interventional Pulmonology Market
6.3.4.4.1 South Korea Interventional Pulmonology Market by Product
6.3.4.4.2 South Korea Interventional Pulmonology Market by Indication
6.3.4.4.3 South Korea Interventional Pulmonology Market by End-user
6.3.4.5 Singapore Interventional Pulmonology Market
6.3.4.5.1 Singapore Interventional Pulmonology Market by Product
6.3.4.5.2 Singapore Interventional Pulmonology Market by Indication
6.3.4.5.3 Singapore Interventional Pulmonology Market by End-user
6.3.4.6 Malaysia Interventional Pulmonology Market
6.3.4.6.1 Malaysia Interventional Pulmonology Market by Product
6.3.4.6.2 Malaysia Interventional Pulmonology Market by Indication
6.3.4.6.3 Malaysia Interventional Pulmonology Market by End-user
6.3.4.7 Rest of Asia Pacific Interventional Pulmonology Market
6.3.4.7.1 Rest of Asia Pacific Interventional Pulmonology Market by Product
6.3.4.7.2 Rest of Asia Pacific Interventional Pulmonology Market by Indication
6.3.4.7.3 Rest of Asia Pacific Interventional Pulmonology Market by End-user
6.4 LAMEA Interventional Pulmonology Market
6.4.1 LAMEA Interventional Pulmonology Market by Product
6.4.1.1 LAMEA Bronchoscopes Market by Country
6.4.1.2 LAMEA Electromagnetic Navigation Bronchoscopy System Market by Country
6.4.1.3 LAMEA Bronchial Thermoplasty Systems Market by Country
6.4.1.4 LAMEA Pleuroscopes Market by Country
6.4.1.5 LAMEA Respiratory Endotherapy Devices Market by Country
6.4.1.6 LAMEA Endobronchial Valves Market by Country
6.4.1.7 LAMEA Airway Stents & Pleural Catheters Market by Country
6.4.2 LAMEA Interventional Pulmonology Market by Indication
6.4.2.1 LAMEA Asthma Market by Country
6.4.2.2 LAMEA Lung Cancer Market by Country
6.4.2.3 LAMEA COPD Market by Country
6.4.2.4 LAMEA Tracheal & Bronchial Stenosis Market by Country
6.4.2.5 LAMEA Others Market by Country
6.4.3 LAMEA Interventional Pulmonology Market by End-user
6.4.3.1 LAMEA Hospitals Market by Country
6.4.3.2 LAMEA Ambulatory Surgical Centers Market by Country
6.4.3.3 LAMEA Diagnostic Centers Market by Country
6.4.3.4 LAMEA Specialty Clinics Market by Country
6.4.3.5 LAMEA Others Market by Country
6.4.4 LAMEA Interventional Pulmonology Market by Country
6.4.4.1 Brazil Interventional Pulmonology Market
6.4.4.1.1 Brazil Interventional Pulmonology Market by Product
6.4.4.1.2 Brazil Interventional Pulmonology Market by Indication
6.4.4.1.3 Brazil Interventional Pulmonology Market by End-user
6.4.4.2 Argentina Interventional Pulmonology Market
6.4.4.2.1 Argentina Interventional Pulmonology Market by Product
6.4.4.2.2 Argentina Interventional Pulmonology Market by Indication
6.4.4.2.3 Argentina Interventional Pulmonology Market by End-user
6.4.4.3 UAE Interventional Pulmonology Market
6.4.4.3.1 UAE Interventional Pulmonology Market by Product
6.4.4.3.2 UAE Interventional Pulmonology Market by Indication
6.4.4.3.3 UAE Interventional Pulmonology Market by End-user
6.4.4.4 Saudi Arabia Interventional Pulmonology Market
6.4.4.4.1 Saudi Arabia Interventional Pulmonology Market by Product
6.4.4.4.2 Saudi Arabia Interventional Pulmonology Market by Indication
6.4.4.4.3 Saudi Arabia Interventional Pulmonology Market by End-user
6.4.4.5 South Africa Interventional Pulmonology Market
6.4.4.5.1 South Africa Interventional Pulmonology Market by Product
6.4.4.5.2 South Africa Interventional Pulmonology Market by Indication
6.4.4.5.3 South Africa Interventional Pulmonology Market by End-user
6.4.4.6 Nigeria Interventional Pulmonology Market
6.4.4.6.1 Nigeria Interventional Pulmonology Market by Product
6.4.4.6.2 Nigeria Interventional Pulmonology Market by Indication
6.4.4.6.3 Nigeria Interventional Pulmonology Market by End-user
6.4.4.7 Rest of LAMEA Interventional Pulmonology Market
6.4.4.7.1 Rest of LAMEA Interventional Pulmonology Market by Product
6.4.4.7.2 Rest of LAMEA Interventional Pulmonology Market by Indication
6.4.4.7.3 Rest of LAMEA Interventional Pulmonology Market by End-user
Chapter 7. Company Profiles
7.1 Medtronic PLC
7.1.1 Company overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 SWOT Analysis
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Trials and Approvals:
7.2.6 SWOT Analysis
7.3 Becton, Dickinson and Company
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 Olympus Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Recent strategies and developments:
7.4.4.1 Acquisition and Mergers:
7.5 Fujifilm Holdings Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Product Launches and Product Expansions:
7.6 ICU Medical, Inc. (Smiths Medical)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 HUGER Medical Instrument Co., Lt
7.7.1 Company Overview
7.8 Cook Medical, Inc. (Cook Group)
7.8.1 Company Overview
7.9 Clarus Medical LLC
7.9.1 Company Overview
7.10. Vygon SAS
7.10.1 Company Overview

Companies Mentioned

  • Medtronic PLC
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Olympus Corporation
  • Fujifilm Holdings Corporation
  • ICU Medical, Inc. (Smiths Medical)
  • HUGER Medical Instrument Co., Ltd
  • Cook Medical, Inc. (Cook Group)
  • Clarus Medical LLC
  • Vygon SAS

Methodology

Loading
LOADING...

Related Topics

Related Reports

Interventional Pulmonology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Interventional Pulmonology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 270 Pages
  • Global
From
Global Interventional Pulmonology Market: Insights & Forecast with Potential Impact of COVID-19 (2024-2028) - Product Image

Global Interventional Pulmonology Market: Insights & Forecast with Potential Impact of COVID-19 (2024-2028)

  • Report
  • 66 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Treatment Global Market Report 2024 - Product Image

Chronic Obstructive Pulmonary Disease (COPD) Treatment Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
COPD and Asthma Devices Market Report by Product, Indication, Distribution Channel, and Region 2024-2032 - Product Image

COPD and Asthma Devices Market Report by Product, Indication, Distribution Channel, and Region 2024-2032

  • Report
  • 137 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) and Asthma Devices Market Report 2024 - Product Image

Chronic Obstructive Pulmonary Disease (COPD) and Asthma Devices Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.